BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 33317626)

  • 1. ELABELA ameliorates hypoxic/ischemic-induced bone mesenchymal stem cell apoptosis via alleviation of mitochondrial dysfunction and activation of PI3K/AKT and ERK1/2 pathways.
    Fu J; Chen X; Liu X; Xu D; Yang H; Zeng C; Long H; Zhou C; Wu H; Zheng G; Wu H; Wang W; Wang T
    Stem Cell Res Ther; 2020 Dec; 11(1):541. PubMed ID: 33317626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide hormone ELABELA promotes rat bone marrow-derived mesenchymal stem cell proliferation and migration by manipulating the cell cycle through the PI3K/AKT pathway under the hypoxia and ischemia microenvironment.
    Chen X; Zhou C; Xu D; Liu X; Li S; Hou J; Zhang K; Zeng C; Zheng G; Wu H; Wu H; Wang W; Fu J; Wang T
    Stem Cell Res Ther; 2022 Jan; 13(1):32. PubMed ID: 35090551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Fc-Elabela-21 on renal ischemia/reperfusion injury in mice: Mediation of anti-apoptotic effect via Akt phosphorylation.
    Xu F; Wu M; Lu X; Zhang H; Shi L; Xi Y; Zhou H; Wang J; Miao L; Gong DW; Cui W
    Peptides; 2022 Jan; 147():170682. PubMed ID: 34742787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lovastatin protects mesenchymal stem cells against hypoxia- and serum deprivation-induced apoptosis by activation of PI3K/Akt and ERK1/2.
    Xu R; Chen J; Cong X; Hu S; Chen X
    J Cell Biochem; 2008 Jan; 103(1):256-69. PubMed ID: 17497701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiopoietin-like 4 confers resistance to hypoxia/serum deprivation-induced apoptosis through PI3K/Akt and ERK1/2 signaling pathways in mesenchymal stem cells.
    Hou M; Cui J; Liu J; Liu F; Jiang R; Liu K; Wang Y; Yin L; Liu W; Yu B
    PLoS One; 2014; 9(1):e85808. PubMed ID: 24465718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosuvastatin enhances the therapeutic efficacy of adipose-derived mesenchymal stem cells for myocardial infarction via PI3K/Akt and MEK/ERK pathways.
    Zhang Z; Li S; Cui M; Gao X; Sun D; Qin X; Narsinh K; Li C; Jia H; Li C; Han Y; Wang H; Cao F
    Basic Res Cardiol; 2013 Mar; 108(2):333. PubMed ID: 23386286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C1q tumor necrosis factor-related protein-3 protects mesenchymal stem cells against hypoxia- and serum deprivation-induced apoptosis through the phosphoinositide 3-kinase/Akt pathway.
    Hou M; Liu J; Liu F; Liu K; Yu B
    Int J Mol Med; 2014 Jan; 33(1):97-104. PubMed ID: 24212403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpressing cellular repressor of E1A-stimulated genes protects mesenchymal stem cells against hypoxia- and serum deprivation-induced apoptosis by activation of PI3K/Akt.
    Deng J; Han Y; Yan C; Tian X; Tao J; Kang J; Li S
    Apoptosis; 2010 Apr; 15(4):463-73. PubMed ID: 19997978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ELABELA improves endothelial cell function via the ELA-APJ axis by activating the PI3K/Akt signalling pathway in HUVECs and EA.hy926 cells.
    Wang X; Liang G; Guo Q; Cai W; Zhang X; Ni J; Tao Y; Niu X; Chen S
    Clin Exp Pharmacol Physiol; 2020 Dec; 47(12):1953-1964. PubMed ID: 32687618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte growth factor (HGF) and stem cell factor (SCF) maintained the stemness of human bone marrow mesenchymal stem cells (hBMSCs) during long-term expansion by preserving mitochondrial function via the PI3K/AKT, ERK1/2, and STAT3 signaling pathways.
    Cao Z; Xie Y; Yu L; Li Y; Wang Y
    Stem Cell Res Ther; 2020 Jul; 11(1):329. PubMed ID: 32736659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ELABELA Is an Endogenous Growth Factor that Sustains hESC Self-Renewal via the PI3K/AKT Pathway.
    Ho L; Tan SY; Wee S; Wu Y; Tan SJ; Ramakrishna NB; Chng SC; Nama S; Szczerbinska I; Chan YS; Avery S; Tsuneyoshi N; Ng HH; Gunaratne J; Dunn NR; Reversade B
    Cell Stem Cell; 2015 Oct; 17(4):435-47. PubMed ID: 26387754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat shock protein 90 protects rat mesenchymal stem cells against hypoxia and serum deprivation-induced apoptosis via the PI3K/Akt and ERK1/2 pathways.
    Gao F; Hu XY; Xie XJ; Xu QY; Wang YP; Liu XB; Xiang MX; Sun Y; Wang JA
    J Zhejiang Univ Sci B; 2010 Aug; 11(8):608-17. PubMed ID: 20669351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elabela, a Novel Peptide, Exerts Neuroprotective Effects Against Ischemic Stroke Through the APJ/miR-124-3p/CTDSP1/AKT Pathway.
    Zhang KL; Li SM; Hou JY; Hong YH; Chen XX; Zhou CQ; Wu H; Zheng GH; Zeng CT; Wu HD; Fu JY; Wang T
    Cell Mol Neurobiol; 2023 Aug; 43(6):2989-3003. PubMed ID: 37106272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleus pulposus cells upregulate PI3K/Akt and MEK/ERK signaling pathways under hypoxic conditions and resist apoptosis induced by serum withdrawal.
    Risbud MV; Fertala J; Vresilovic EJ; Albert TJ; Shapiro IM
    Spine (Phila Pa 1976); 2005 Apr; 30(8):882-9. PubMed ID: 15834331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ELABELA-APJ axis protects from pressure overload heart failure and angiotensin II-induced cardiac damage.
    Sato T; Sato C; Kadowaki A; Watanabe H; Ho L; Ishida J; Yamaguchi T; Kimura A; Fukamizu A; Penninger JM; Reversade B; Ito H; Imai Y; Kuba K
    Cardiovasc Res; 2017 Jun; 113(7):760-769. PubMed ID: 28371822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic infusion of ELABELA alleviates vascular remodeling in spontaneously hypertensive rats via anti-inflammatory, anti-oxidative and anti-proliferative effects.
    Ye C; Geng Z; Zhang LL; Zheng F; Zhou YB; Zhu GQ; Xiong XQ
    Acta Pharmacol Sin; 2022 Oct; 43(10):2573-2584. PubMed ID: 35260820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetramethylpyrazine Protects Bone Marrow-Derived Mesenchymal Stem Cells against Hydrogen Peroxide-Induced Apoptosis through PI3K/Akt and ERK1/2 Pathways.
    Fang Y; Chu L; Li L; Wang J; Yang Y; Gu J; Zhang J
    Biol Pharm Bull; 2017 Dec; 40(12):2146-2152. PubMed ID: 28978811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Elabela-APJ axis: a promising therapeutic target for heart failure.
    Ma Z; Song JJ; Martin S; Yang XC; Zhong JC
    Heart Fail Rev; 2021 Sep; 26(5):1249-1258. PubMed ID: 32314083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of insulin-like growth factor 1 exerts a protective effect on hypoxic injury of aged BM-MSCs: role of autophagy.
    Yang M; Wen T; Chen H; Deng J; Yang C; Zhang Z
    Stem Cell Res Ther; 2018 Oct; 9(1):284. PubMed ID: 30359321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SDF-1α inhibits hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells through PI3K/Akt and ERK1/2 signaling pathways.
    Yin Q; Jin P; Liu X; Wei H; Lin X; Chi C; Liu Y; Sun C; Wei Y
    Mol Biol Rep; 2011 Jan; 38(1):9-16. PubMed ID: 20383584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.